Peter C. Brandt, Director at REXAHN PHARMACEUTICALS, INC. (RNN), bought 125,000 shares at $1.22 ($147K) on 2011-09-09, disclosed to the SEC on 2011-09-12.
Open-market purchase of $147k RNN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.08 | 15,000 | $16K | 11.0% |
| 2 | $1.09 | 5,912 | $6K | 4.4% |
| 3 | $1.10 | 2,500 | $3K | 1.9% |
| 4 | $1.10 | 13,800 | $15K | 10.3% |
| 5 | $1.12 | 7,200 | $8K | 5.5% |
| 6 | $1.13 | 588 |
| $664 |
| 0.5% |
| 7 | $1.21 | 6,600 | $8K | 5.4% |
| 8 | $1.22 | 13,300 | $16K | 11.0% |
| 9 | $1.22 | 55,100 | $67K | 45.8% |
| 10 | $1.23 | 5,000 | $6K | 4.2% |
| Total | $1.18 avg | 125,000 | $147K | 100% |
| Filing → |
| EPOC | BUY | 2011-09-09 | $142K | — | Filing → |
| EPOC | BUY | 2011-09-08 | $100K | — | Filing → |
| RNN | BUY | 2011-09-08 | $24K | — | Filing → |